Nu Skin (NUS) Q3 2026 Earnings Call: Prysm-Momentum und Gesamtjahresprognose

Wichtigste Erkenntnisse

• Nu Skin (NYSE: NUS) meldete für das dritte Quartal 2026 einen Umsatz von 311 Millionen US-Dollar und ein bereinigtes EPS von 0,10 US-Dollar, beide Werte lagen innerhalb der Prognosespannen der Unternehmensführung. Das ausgewiesene EPS belief sich auf minus 0,02 US-Dollar.
• Die bereinigte operative Marge sank im Jahresvergleich von 5,9 % auf 3,7 %. Die Bruttomarge ging vor allem aufgrund des Umsatzmixes zwischen dem Kerngeschäft von Nu Skin und den Rhyz-Aktivitäten auf 65,0 % zurück.
• Die Fertigungsplattform Rhyz erzielte im Jahresvergleich ein starkes Umsatzwachstum, während das Kerngeschäft bei den Kunden- und Vertriebskennzahlen weiterhin unter Druck stand.
• Bis zum Quartalsende wurden weltweit rund 41.000 Prysm-iO-Geräte platziert, die 4,5 Millionen Scans generierten. Nach dem Update auf die Prysm-App 2.0 hat sich die Conversion-Rate von Scans zu Käufen auf 10 % mehr als verdoppelt.
• Nu Skin erwartet für das vierte Quartal einen Umsatz von 310 Millionen bis 340 Millionen US-Dollar und ein bereinigtes EPS von 0,11 bis 0,21 US-Dollar. Die Umsatzprognose für das Gesamtjahr liegt bei 1,26 Milliarden bis 1,29 Milliarden US-Dollar bei einem bereinigten EPS von 0,55 bis 0,65 US-Dollar.
• Die Prioritäten der Unternehmensführung bleiben der Ausbau der Anti-Aging-Plattform, die Stärkung der Kompetenzen der Vertriebsorganisation, die Vorbereitung des offiziellen Marktstarts in Indien im ersten Halbjahr 2027 sowie die Steigerung der Effizienz durch ein Ost-West-Betriebsmodell.

Zentrale Finanzdaten

Geschäftliche und operative Entwicklung

Prysm iO blieb ein zentraler Bestandteil der personalisierten Wellness-Strategie von Nu Skin. Die Plattform verknüpft Ernährungsscans, KI-gestützte Produktempfehlungen und wiederkehrende Produktnutzung. Nach Angaben des Managements verbesserte das Ende August eingeführte Update auf die App 2.0 die Kundenbindung und hat die Conversion-Rate von Scans zu Käufen auf 10 % mehr als verdoppelt.

LifePak, das Flaggschiff-Nahrungsergänzungsmittel des Unternehmens, verzeichnete seit Jahresbeginn im Vorjahresvergleich ein Umsatzwachstum von fast 3 %. Das Management wertete dies als Beleg für die Akzeptanz seiner Wellness-Plattform trotz des Drucks auf die Gesamterlöse.

Die Fertigungsplattform Rhyz verzeichnete im Quartal ein starkes Umsatzwachstum im Jahresvergleich. Im Kerngeschäft von Nu Skin hielt der Druck auf die gesamten Kunden- und Vertriebskennzahlen jedoch weiter an.

Nu Skin passt die Anreize für die Vertriebsorganisation an und baut die Führungskräfteentwicklung aus. Das Management erklärte, der Ansatz verlagere sich von kurzfristigen Werbeaktionen hin zu Vergütungsmodellen, Meilenstein-Anreizen und Schulungen zur Verbesserung der Kunden- und Affiliate-Gewinnung. Die Schulungen konzentrieren sich zunehmend auf soziale Medien, Tracking-Links und direkte digitale Transaktionen.

Das Unternehmen bereitet sich weiterhin auf den offiziellen Marktstart in Indien im ersten Halbjahr 2027 vor. Wie die Geschäftsleitung mitteilte, werden nach der Pre-Marketing-Phase die operativen, produktbezogenen und kommerziellen Pläne verfeinert, wobei der Schwerpunkt auf dem Aufbau eines skalierbaren Marktfundaments liegt.

Nu Skin implementiert zudem eine Ost-West-Betriebsstruktur. Das Unternehmen erwartet, dass eine engere Abstimmung zwischen Fertigung und Endmärkten – mit den USA für westliche und China für östliche Märkte – im Laufe der Zeit die Bruttomarge, die Markteinführungszeit und die Optimierung der Fixkosten unterstützen wird.

Prognose der Unternehmensführung

Die Unternehmensführung rechnet für das vierte Quartal mit einem sequenziellen Umsatzwachstum, gestützt durch Initiativen zur Steigerung der Kunden- und Affiliate-Aktivität im Weihnachtsgeschäft. Für Q4 erwartet das Unternehmen verbleibende zahlungswirksame organisatorische Übergangskosten von rund 5 Millionen US-Dollar; diese Kosten sind in der bereinigten Ergebnisprognose nicht enthalten.

Risiken und Schwerpunkte

• Umsatz sowie Kunden- und Vertriebskennzahlen des Kerngeschäfts stehen weiterhin unter Druck.
• Die Rentabilität wird durch den Umsatzmix zwischen dem margenstärkeren Kerngeschäft von Nu Skin und Rhyz beeinflusst.
• Währungseffekte schmälerten den Umsatz im dritten Quartal um 3,9 Millionen US-Dollar und dürften das Gesamtjahr voraussichtlich weiterhin mit rund 1 % belasten.
• Das Management nannte die Inflation als einen Faktor, der die Budgets der Kunden und deren Produktentscheidungen beeinträchtigt.
• Die Vorteile der Ost-West-Struktur, der Neuausrichtung der Fertigung und des Ausbaus der Vertriebsorganisation hängen von der weiteren Umsetzung ab und dürften sich erst im Zeitverlauf einstellen.
• Die Prysm-App 2.0 befindet sich weiterhin in einem frühen Stadium, und die Unternehmensführung hat kein konkretes mittelfristiges Conversion-Ziel genannt.

Wichtigste Punkte aus der Analysten-Fragerunde

Das Management betonte, dass eine nachhaltige Verbesserung des Vertriebskanals eher durch Änderungen des Vergütungsplans, darauf abgestimmte Meilenstein-Anreize und Kompetenzentwicklung als durch kurzfristige Werbeaktionen erzielt werden könne. Nu Skin passe die Anreize an, um Kundengewinnung und Teamaufbau in Einklang zu bringen, und bereite zugleich seine Anreiz-Roadmap für 2027 vor.

In Bezug auf Prysm wies das Management darauf hin, dass die Konvertierungsrate von 10 % verschiedene Scan-Arten zusammenfasst, darunter wiederholte Scans bestehender Abonnenten. Das Gerät soll sowohl die Kundengewinnung als auch die Kundenbindung unterstützen. Das Management geht davon aus, dass die Conversion weiter steigen kann, sobald das KI-System die Kundenbedürfnisse besser erfasst und gestaffelte Produktempfehlungen basierend auf Ernährungsprioritäten und Budgets bereitstellt; ein konkretes beziffertes Ziel nannte es jedoch nicht.

Vollständiges Transkript der Telefonkonferenz

Vollständiges Transkript der Telefonkonferenz

Ausführungen des Managements

Operator

[Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, VP of Investor Relations, B.G. Hunt. Please go ahead.

B.G. Hunt

Thanks, Janelle, and good afternoon, everyone. I'm joined by Ryan Napierski, President and CEO, and by our interim CFO, Chelsea Lantz.

Today we'll be sharing Nu Skin's Q3 2026 results and providing guidance for the remainder of the year. Before I turn the time over to Ryan, let me point out that on today's call, comments will be made that include forward-looking statements. These statements involve important risks and uncertainties, and actual results may differ materially from those discussed or anticipated. Please refer to today's earnings release and our SEC filing for complete discussion of these risks. Also during the call, certain financial numbers may be discussed that differ from comparable numbers obtained in our financial statements. We believe these non-GAAP numbers assist in comparing period-to-period results in a more consistent manner. Please refer to our investor website, ir.nuskin.com, for any required reconciliation of these non-GAAP numbers. And with that, I'd like to now turn the call over to Ryan.

Ryan Napierski

Thanks, B.G. Good afternoon, everyone, and thanks for joining for our third quarter call. We delivered revenue of $311 million and adjusted EPS of $0.10, both within our guidance range. Our Rhyz manufacturing platform had an exceptional quarter, posting strong year-over-year revenue growth. While our results reflect ongoing pressures in the core business, we remain focused on our strategic priorities that we've outlined over the last year. Our Chief Operating Officer, Chayce Clark, has been leading the team to simplify, focus, and execute upon each of them. These priorities are: #1, advancing our integrated anti-aging platform; #2, strengthening our channel through improved sales force activation and development; #3, preparing for our formal launch of India early next year; and #4, improving our operating model to support greater profitability over time. Let me briefly update you on each of these priorities. So first, we continue to make progress in advancing our integrated anti-aging platform with Prysm iO playing an increasingly important role in our approach to personalized wellness.

Prysm is designed to help consumers better understand their nutritional health status and engage more consistently with our wellness product solutions, creating a differentiated experience that connects technology, products, and ongoing customer relationships. Since launching Prysm through the end of Q3, we've now placed approximately 41,000 devices globally and completed 4.5 million scans. During the quarter, we rolled out version 2.0 of the app, which delivers a meaningfully improved user experience powered by our new intelligent AI integration. Since the app update, we've more than doubled our scan-to-purchase conversion rate to 10%, which tells us that consumers are taking action when we get them more engaged with the platform. We also see this in demand for LifePak, our flagship nutritional supplement, as sales grew nearly 3% year-over-year year-to-date, a meaningful proof point given the broader revenue environment. We remain encouraged by the potential of this intelligent wellness platform to deepen customer engagement, support recurring product consumption, and provide our sales leaders with meaningful differentiation in the marketplace.

In September, we hosted our global Nu Skin Live convention in Yokohama, Japan with approximately 12,000 sales leaders from around the world. We previewed upcoming innovations in our anti-aging portfolio with a particular focus on women's health, which will begin rolling out mid-2027. We will share a future product pipeline with you as we move into next year. Second, we continue to invest in the capabilities necessary to strengthen our talented and committed global sales channel. We recognize that innovative products alone are not enough to drive sustainable growth. Equally important is our ability to empower our dedicated brand affiliates and sales leaders to effectively introduce our products, engage with our customers, and build successful businesses. Over the past several years, we've focused on improving the simplicity, accessibility, and effectiveness of our sales compensation incentive system.

We have also begun expanding our investments into leadership learning and development by providing unique opportunities for leaders to acquire and strengthen critical success capabilities in selling products, acquiring customers and brand affiliates, building sales teams, and leading large organizations. At Live, we held a dedicated live leadership training session with industry-renowned trainer Eric Worre and our Team Elite top sales leaders. We've also just wrapped up a two-day leadership management event, our Management Mastermind event earlier this week with nearly 2,000 of our most engaged sales leaders from around the globe. These investments are designed to further empower our talented sales leaders and strengthen their development of the next generation of leadership for Nu Skin. Although our overall customer and sales metrics remain under pressure, we believe these new investments are important to rebuilding engagement and productivity, which is the foundation for more sustainable performance in our channel into the future. Third, we continue to prepare for our anticipated formal launch of India during the first half of 2027. India represents an attractive long-term market opportunity supported by its large consumer population, growing interest in health and wellness, and an expanding entrepreneurial economy.

We've acquired many learning streams during our pre-marketing period and our teams are focused now on refining operational product and commercial preparations necessary to support a successful and scalable full market launch. We are approaching this opportunity with a long-term perspective as we focus on building the right foundation for sustainable growth. And finally, we remain focused on improving efficiency and profitability of our global business. As we continue to align our operations with current market conditions, we are evaluating opportunities to simplify our organization, improve productivity, and better leverage our global capabilities. Chayce is also leading an effort across the company to realign the organization around our East-West structure, which will enable the company to meet the unique needs of our business across these two hemispheres. Each region is now focused on building and executing successful go-to-market plans, including incentive roadmaps, product introductions, and promotions, in order to improve customer and affiliate acquisition and retention. We believe that aligning our organization around this East-West structure will also result in greater efficiencies and cost performance as we leverage our manufacturing hubs in both the U.S. for our western market needs and China to better serve our eastern markets.

Moving manufacturing closer to the customer is expected to improve gross margin, speed to market, and fixed cost optimization over time. While there is more work ahead, we believe disciplined execution against these priorities will help the company improve efficiencies and profitability as our business performance strengthens. Looking ahead to the fourth quarter, our focus remains on driving customer and affiliate engagement through the holiday seasons as we anticipate sequential revenue growth. As we prepare for 2027, we remain committed to the strategic priorities we've outlined throughout the year: again, advancing our anti-aging platform, strengthening our sales channel, preparing for India's formal launch, and improving our operating efficiency. We believe these initiatives position Nu Skin for improved performance and sustainable growth long-term. So with that, I'll turn the time over to Chelsea to review our financials.

Chelsea Lantz

Thanks, Ryan. Good afternoon, everyone. Today I'll review our third quarter results and discuss our outlook for the remainder of the year. Third quarter revenue was $311 million within the guidance range, including an approximate 1.1% or $3.9 million foreign currency headwind. Reported earnings per share were negative $0.02 or a positive $0.10, excluding organizational transition costs related to the implementation of our ERP, East-West operating model, and certain other charges. Adjusted earnings per share were in line with our guidance range. Gross margin for the quarter was 65% compared to 70.5% in the prior year, primarily reflecting the revenue mix between our Nu Skin core and Rhyz businesses. Within the core Nu Skin business, gross margin was 76.6% compared to 77.7% in the prior year. We remain committed to our gross margin improvement initiatives through pricing discipline, product mix optimization, and operational efficiencies within the core business.

Selling expense as a percentage of revenue was 33.2% compared to 35.8% in the prior year. Within the core Nu Skin business, selling expense was 40.9% compared to 41.7% in the prior year. We continue to target core selling expense around 40%. General and administrative expenses declined by $10.9 million year-over-year to 30.2% of revenue compared to 28.8% in the prior year. As we continue to right-size our fixed cost base to current operations while preserving investment in key strategic priorities. Adjusted operating margin for the quarter was 3.7% compared to 5.9% in the prior year. We continue to make progress on the implementation of the East-West operating model announced last quarter to better align our resources with the needs of our markets. We currently anticipate approximately $5 million in remaining cash-based organizational transition costs in the fourth quarter, which have been excluded from our adjusted earnings guidance.

On the balance sheet, we ended the quarter with $164.9 million of cash and cash equivalents and reduced our total debt to $203.7 million. We remain focused on disciplined capital allocation and returned $2.9 million to shareholders through dividends during the quarter. We did not repurchase shares, leaving $137.3 million remaining under our current authorization. Turning to our outlook for the fourth quarter and full year. For the fourth quarter, we expect revenue in the range of $310 million to $340 million, including an anticipated foreign currency tailwind of approximately 1%. We expect reported earnings per share in the range of $0.05 to $0.15 or adjusted earnings per share of $0.11 to $0.21. For the full year, we now expect revenue of $1.26 billion to $1.29 billion, including an anticipated foreign currency headwind of approximately 1%.

We expect annual reported earnings per share of negative $5.08 to negative $4.98, reflecting the impact of the second quarter goodwill impairment and deferred tax valuation allowance, which did not affect our cash position or ability to execute on our strategic plan. On an adjusted basis, we expect annual earnings per share of $0.55 to $0.65, excluding these non-cash items, certain other year-to-date charges, and anticipated fourth quarter organizational transition costs. After these adjustments, our guidance reflects an effective tax rate for the year of approximately 39%. As discussed today, we are taking deliberate steps to strengthen the business from optimizing our cost structure to evolving our operating model. Our focus remains on disciplined execution and improving profitability, and we're confident these actions will position us for sustainable growth in the periods ahead. With that, operator, we'll now open the line for questions.

Operator

[Operator Instructions]

Our first question comes from the line of Dave Storms with StoneGate.

Fragen und Antworten

David Storms

I know you guys are busy between India and Prysm, so I'll try to be brief here. Just a couple. Ryan, when you were talking about strengthening the sales channel and obviously trying to grow the customer base, I recognize that sometimes the customer base can follow the leaders, leaders can follow the customers, a bit of a push and pull there. Are there any incentives to highlight here that might bring that back beyond what you talked about with all the leadership initiatives that you have?

Ryan Napierski

Yes, so a lot of the leadership initiatives, Dave, that we are focused on are really around how do we enhance the customer acquisition and brand affiliate acquisition, and that really is the focus for us. As we have learned over the course of the last few years, incentives and short-term promotions are not as helpful at building channel momentum as more of a sustained programmatic approach. So when I mention kind of the three levers, you have the compensation system itself, the incentive roadmap that layers on top of that, that kind of recognizes and rewards key development. Those have kind of been our two levers that we've been really working to ensure that they're right for the market. So some compensation plan enhancements have been rolling around the world over the course of this past year to right-size the incentives for customer acquisition versus team building, for instance. And then we've been working, especially in the second half, to realign our incentive roadmap, again, these key milestone areas, to ensure that those are fully aligned for the 2027 year. This third piece though that we're talking about really is this learning and development platform that we're talking about for our leadership.

And it really is focusing on core skills and capabilities that are needed in the market, and a lot of that is related to just the changes in the marketplace over the course of the last 5 to 10 years. Today, the way that our affiliates build the business in terms of sharing products on social media, posting, sharing, commenting, DMing, that's a very different set of skills and capabilities than the way they used to do the job, what we used to call them distributors, where they would buy products wholesale and sell those. So the vast majority of our customers today transact on our platform directly through links, attributed links through social media, etc. And so we've realized that these skills, these capabilities, and the shift—and it's very different by market, different markets at different stages—but that's really where we need to focus: less on the short term, more on the systemic and sustainable skills and capabilities.

Chelsea Lantz

I would just add, and I said in my prepared remarks, but as we look at these changes and balancing our approach from a strategic standpoint, we do feel like 40% is the right level from a cost perspective. So that's how we're modeling it in our models for the core business.

David Storms

Understood. That's great. I appreciate that. And then just did want to maybe get a temperature check on Prysm. I know we've talked in the past about—I appreciate the new commentary around 10% scan-to-purchase conversion rate. Add in, you know, version 2.0 app, it sounds like there's a lot of tailwinds there. I think honing in on the conversion rate, how should we think about the success? I mean, is 10% just getting started, or what you would expect to see in the medium term? Just any thoughts there.

Ryan Napierski

Yes, no, I mean it's pretty interesting. So as I mentioned, if we just kind of do the simple math—and you'll have to do it for me here—4.5 million scans over 41,000 units. We're talking about many scans per unit that we are seeing. Some of that is self-scanning, others guest scanning, so we kind of are tracking all of this data differently. The 10% really is kind of an aggregation of that process. And so I think there's a lot of room for improved conversion when you think of the total scans.

But this device is unique because it plays a role for both acquiring new customers as well as retaining customers on the device. So, for example, I scan myself twice a week. I'm already on a subscription, right? And so obviously my conversion with each of my scans and such, that's not driving that 10% rate. I really do believe, and we're still in the early stage of this, what we have learned with the 2.0 and this new intelligent AI, the increased interactivity between the app and the customer with respect to their personalized product recommendation and the insights they gather through that AI algorithmic approach is really creating a greater engagement level. We are happy to see—we're very early, I think 2.0 rolled out the latter part of August, last week of August, so we're really talking about kind of a doubling within a month's time. And I think there's room upwards. I don't know that I could give you an exact number, but we certainly haven't hit the top there. I would hope to see that that can increase significantly from there, the smarter that intelligence gets in understanding that customer's needs and kind of helping them navigate which product solution set—kind of we do a good, better, best recommendation—which set is going to best meet their needs. And those needs also, by the way, include their pocketbook.

Obviously, inflation is heavy right now. Our app does look in kind of a good, better, best scenario to say where is the essential nutrition that you need versus kind of a more extensive and then optimal level. So we do try to give consumer choices to play into that.

David Storms

That's great, [ Carl ]. I really appreciate that. That's all I have. I appreciate the time, and good luck in the next quarter.

B.G. Hunt

All right, thanks, Dave.

Operator

I'm showing no further questions at this time. I would now like to turn the conference back to President and CEO Ryan Napierski for closing remarks.

Ryan Napierski

Well, truly, you know, we're in the day-to-day here at Nu Skin working with our sales leaders around the world, our teams in nearly 50 markets around the world. And it's always interesting to me when we get to go interact with this team and our teams and to see the dedication of our employees around the world, the dedication of our sales leaders to the mission of this company to be a global force for good by empowering people to look, feel, and live better. And they feel this truly to their bones, and it's just very inspiring to me. Our mission is absolutely needed in the world today. We're absolutely committed to delivering it, to leveraging technology to do it better through our sales force, who is ultimately the key to our success. And so with that, we'll plan to keep you updated quarter to quarter as our journey continues.

And we thank you for your support and your ongoing interest as we move forward. Thank you, everybody.

Operator

Thank you for your participation in today's conference. This does conclude the program. You may now disconnect.

This live transcript is auto-generated without human intervention or review.